These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36756387)

  • 1. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
    Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
    Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.
    Zhang Y; Ma JP; Weng JC; Wang L; Wu Z; Li D; Zhang JT
    Neurosurg Rev; 2021 Apr; 44(2):1003-1015. PubMed ID: 32189095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
    J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
    Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
    J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
    Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
    J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
    Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
    Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
    Kiang KM; Chan AA; Leung GK
    BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients.
    Kavouridis VK; Ligon KL; Wen PY; Iorgulescu JB
    J Neurooncol; 2022 May; 158(1):111-116. PubMed ID: 35474499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.
    Castelli J; Feuvret L; Haoming QC; Biau J; Jouglar E; Berger A; Truc G; Gutierrez FL; Morandi X; Le Reste PJ; Thillays F; Loussouarn D; Nouhaud E; Crehange G; Antoni D; Vauleon E; de Crevoisier R; Noel G
    J Neurooncol; 2016 Aug; 129(1):85-92. PubMed ID: 27169763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcoma.
    Dejonckheere CS; Böhner AMC; Koch D; Schmeel LC; Herrlinger U; Vatter H; Schneider M; Schuss P; Giordano FA; Köksal MA
    Strahlenther Onkol; 2022 May; 198(5):468-474. PubMed ID: 34939129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments of gliosarcoma of the brain: a systematic review and meta-analysis.
    Wang X; Jiang J; Liu M; You C
    Acta Neurol Belg; 2021 Dec; 121(6):1789-1797. PubMed ID: 33156945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
    Jin MC; Liu EK; Shi S; Gibbs IC; Thomas R; Recht L; Soltys SG; Pollom EL; Chang SD; Hayden Gephart M; Nagpal S; Li G
    Front Oncol; 2020; 10():337. PubMed ID: 32219069
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical characteristics and disease-specific prognostic nomogram for primary gliosarcoma: a SEER population-based analysis.
    Feng SS; Li HB; Fan F; Li J; Cao H; Xia ZW; Yang K; Zhu XS; Cheng TT; Cheng Q
    Sci Rep; 2019 Jul; 9(1):10744. PubMed ID: 31341246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
    Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
    J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliosarcoma: a clinical and radiological analysis of 48 cases.
    Yi X; Cao H; Tang H; Gong G; Hu Z; Liao W; Sun L; Chen BT; Li X
    Eur Radiol; 2019 Jan; 29(1):429-438. PubMed ID: 29948068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report].
    Kalita O; Zlevorová M; Megová M; Vaverka M; Trojanec R; Tučková L
    Klin Onkol; 2016; 29(6):454-459. PubMed ID: 27951723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
    Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
    J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.
    Frandsen S; Broholm H; Larsen VA; Grunnet K; Møller S; Poulsen HS; Michaelsen SR
    Front Oncol; 2019; 9():1425. PubMed ID: 31921679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.